Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 CNS 1

Conditions

Brain Neoplasms 101 Glioblastoma 85 Glioma 58 Central Nervous System Neoplasms 34 Astrocytoma 27 Neuroblastoma 26 Gliosarcoma 19 Breast Neoplasms 19 Neoplasms 18 Oligodendroglioma 17 Recurrence 14 Neoplasm Metastasis 13 Medulloblastoma 12 Ependymoma 11 Carcinoma, Non-Small-Cell Lung 11 Lymphoma 9 Sarcoma 8 Osteosarcoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroma, Acoustic 7 Meningioma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Follicular 7 Lung Neoplasms 7 Hodgkin Disease 7 Burkitt Lymphoma 7 Wilms Tumor 6 Sezary Syndrome 6 Neuroectodermal Tumors, Primitive 6 Mycosis Fungoides 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Hyperglycemia × CNS × Clear all

NCT03235934 2021-10-25

Glycemic Impact on Glioblastoma Outcomes

University Health Network, Toronto

Glioblastoma, Hyperglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡